What is Breast Imaging Technology?
Breast Imaging Technology market is expected to grow in the future due to technological advancements and the rising prevalence of breast cancer. Increasing demand for breast cancer screening and improving reimbursement scenarios are expected to boost the market in the forecasted period. The 3-D tomosynthesis segment is identified as the fastest-growing segment in the breast imaging market. The use of AI in breast imaging technology is trending in the market.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Hologic, Inc. (United States), GE Healthcare (United States), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Fujifilm Holdings Corporation (Japan), Canon Inc. (Japan), Aurora Healthcare US Corp. (United States), Allengers (India), Dilon Technologies, Inc. (United States), Planmed Oy (Finland) and Delphinus Medical Technologies, Inc.(United States) |
The study covers a detailed analysis segmented by key business segments i.e. by type (Ionizing Breast Imaging Technologies [Mammography (FFDM, Digital & 3D Mammography), PEM, PET-CT, MBI/BSGI, CBCT] and Non-ionizing Breast Imaging Technologies [Breast Ultrasound, Breast MRI, AWBU, Breast Thermography, Electric Impedance Tomography, Optical Imaging]) , by application (Hospitals & Clinics, Breast Care Centers and Diagnostic Imaging Centers) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Breast Imaging Technology market throughout the predicted period.
The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Breast Imaging Technology market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Players, some of them are Hologic, Inc. (United States), GE Healthcare (United States), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Fujifilm Holdings Corporation (Japan), Canon Inc. (Japan), Aurora Healthcare US Corp. (United States), Allengers (India), Dilon Technologies, Inc. (United States), Planmed Oy (Finland) and Delphinus Medical Technologies, Inc.(United States).
Market Overview:
On 10th March 2022, Hologic, Inc., a global leader in women's health, announced that Bolder Surgical, which it recently acquired, was named to Fast Company's annual list of the World's Most Innovative Companies. Hologic has acquired Bolder Surgical, a developer and manufacturer of advanced energy vessel sealing and dissection tools for surgical gynecologists in both laparoscopic and open procedures.
The Committee shall advise FDA on developing appropriate quality standards and regulations for mammography facilities; developing appropriate standards and regulations for bodies accrediting mammography facilities under this program; developing regulations regarding sanctions; developing procedures for monitoring compliance with standards; establishing a mechanism to investigate consumer complaints, and reporting new developments concerning breast imaging that should be considered.
The competitive landscape of the breast imaging technology market provides information about a competitor. Company overview, financials, revenue generated, market potential, investment in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance are all included. The data points presented above are solely related to the companies focus on the breast imaging technology market.
Influencing Trend:
Technological Advancements in Breast Imaging such as Molecular Breast Imaging, Digital Mammogram and Use of AI in Breast Imaging Technology
Market Growth Drivers:
Rising Prevalence of Breast Cancer and Increasing Number of Conferences and Symposiums Focusing on Spreading Awareness about the Benefits of Early Screening and Diagnosis
Challenges:
Increasing Adoption of Refurbished Imaging Systems
Restraints:
The High Cost of Breast Imaging System and Stringent Regulatory Approval Procedures
Opportunities:
Improvement in Reimbursement Scenario in the Healthcare Industry in Developing Region and Emerging Economies Offer High Growth Potential in the Market
Key highlights of the Global Breast Imaging Technology market Study:
CAGR of the market during the forecast period 2022-2028
In-depth information on growth factors that will accelerate the Breast Imaging Technology market in next few years.
Detailed Insights on futuristic trends and changing consumer behavior
Forecast of the Global Breast Imaging Technology market size and its contribution to the parent market by type, application and by country.
A broad view of customer demand
Uncover markets competitive landscape and in-depth information on various Players
Comprehensive information about factors that will challenge the growth of Breast Imaging Technology Players
Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
A tipping point in globalization
A major slowdown in Western economies
Significant shifts in technology and cost structure
The challenges of regulatory compliance
New forms of competition developing
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Breast Imaging Technology market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Breast Imaging Technology market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Breast Imaging Technology Provider, Healthcare Industry, Potential Investors, Technology Investors, Research Firm and Government Agencies.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.